Cabergoline Tablet
Product Images NDC 69238-2693

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 69238-2693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cabergoline Tablets 1)

Chemical structure of cabergoline, showing its molecular framework including multiple rings, nitrogen atoms, and oxygen functional groups. The diagram depicts the arrangement of atoms and bonds characterizing the active ingredient cabergoline.*

FDA Label Image

Label (Cabergoline Tablets 2)

Cabergoline Tablets, USP 0.5 mg oral tablets label from Amneal Pharmaceuticals NY LLC. The label states the quantity as 8 tablets, includes storage instructions between 20°C to 25°C, and notes the product is manufactured by Ritsa Pharma Private Limited in India. The label features the product NDC 69238-2693-1, a barcode, and a designated unvarnished area of 15 mm by 50 mm.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.